Skip to main content
News

Schizophrenia statistics

20 million people have schizophrenia but less than a third receive treatment. These schizophrenia statistics illustrate the prevalence and treatment gap of the disorder.

Key takeaways

  • Schizophrenia is a chronic, severe mental illness that affects perception, thinking, and daily functioning, is often misunderstood, and presents with a wide range of symptoms that vary by individual.

  • While schizophrenia affects millions worldwide and carries significant risks—including disability, suicide, stigma, and socioeconomic burden—effective treatments and early intervention can substantially improve long-term outcomes.

  • Ongoing research, improved medications, therapy, and efforts to reduce stigma offer growing hope for better symptom management, quality of life, and societal inclusion for people with schizophrenia.

The word “schizophrenia” comes from Greek origins, with “schizo” meaning “split” and “phrene” meaning “mind.” Schizophrenia is different from dissociative identity disorder, previously known as split personality disorder, which is a common misconception. There are many symptoms of schizophrenia, and individuals can experience them in different ways. Schizophrenia is a chronic mental illness that usually develops in early adulthood. Although symptoms are often worse at the onset of the condition, established and emerging treatment options are available and effective.

What is schizophrenia?

Schizophrenia is a chronic and severe mental disorder that affects thoughts, feelings, and behaviors. That can affect a person’s perception of reality, social interactions, and thought processes. 

Symptoms of schizophrenia include:

  • Hallucinations: These may include visual (seeing things that aren’t there) or auditory (hearing voices) hallucinations.
  • Delusions: These are false beliefs that a person holds, even when there is evidence they are not true.
  • Cognitive impairment: Unusual ways of thinking or disorganized speech 
  • Difficulty in social relationships 

Certain chemical imbalances in the brain, genetic traits, and environmental factors are risk factors for schizophrenia. The major types of schizophrenia include paranoid schizophrenia, catatonic schizophrenia, undifferentiated schizophrenia, and schizoaffective disorder.

“Research suggests a combination of physical, genetic, psychological, and environmental factors can make a person more likely to develop the condition, and the condition runs in families, but no single gene has been found to be responsible,” says Judy Ho, Ph.D., a clinical neuropsychologist based in California and host of the SuperCharged Life podcast.

Schizophrenia also includes negative symptoms, which are those that take away behaviors or processes that are considered normal. Melissa Mueller-Douglas, LMSW, a therapist in Rochester, New York, describes some of the negative symptoms of schizophrenia:

  • Poverty of speech: Minimal speech or giving short responses to questions.
  • Anhedonia: Lack of pleasure from activities and interests that people used to enjoy. This leads to decreased involvement in the community and affects quality of life.
  • Affective deficits: A significantly reduced intensity in emotional expression. This can affect personal relationships with family and friends.
  • Lack of motivation: A person may lack the internal motivation to follow through with everyday tasks, such as getting ready in the morning.

The symptoms of schizophrenia can impact the flow of everyday life, such as the “ability to work, have functional relationships, or take care of themselves,” says Ho. “Individuals with floridly psychotic states almost always see their activities of daily functioning fall to the wayside, and they often will need structured intervention (i.e., via psychiatrist or psychologist) for most of their lives to keep symptoms at bay and to make sure their [support] team is in place in case they have a resurgence.”

How many people are affected by schizophrenia?

  • Schizophrenia affects more than 23 million people worldwide. (Frontiers in Psychiatry, 2025)
  • The number of new cases of schizophrenia is 1.2 million per year. (Frontiers in Psychiatry, 2025)
  • Schizophrenia is the third leading cause of disability worldwide. (Frontiers in Psychiatry, 2025)
  • Approximately 5% of people with schizophrenia die by suicide, usually with a higher risk at the onset of the mental illness. (Archives of General Psychiatry, 2005)
  • About 20% of people with schizophrenia attempt suicide at least once. The risk is highest for young males who also use alcohol or drugs. (The Recovery Village, 2026)

Schizophrenia statistics in the United States

  • The prevalence of schizophrenia among U.S adults is estimated to be about 3.7 million, or 1.2% of adults between the ages of 18 and 65. (Treatment Advocacy Center, 2026) 
  • Schizophrenia is often diagnosed in young people during their late teens to early thirties, with symptoms commonly presenting earlier in males than in females. (National Institute of Mental Health, 2018)
  • The National Institute of Mental Health estimates that a person with schizophrenia in the U.S. lives an average of 28.5 fewer years than someone without the condition. (The Recovery Village, 2026)

Schizophrenia demographics by race, ethnicity, and gender

  • In the U.S., black Americans have approximately twice the risk of being diagnosed with schizophrenia compared with white Americans. (JAMA Psychiatry, 2024)
  • Schizophrenia diagnosis was lowest in Asian and Hawaiian/Pacific Islander populations. Hispanic and American Indian/Native Alaskan people have a slightly higher prevalence of schizophrenia than white populations. (Journal of American Psychiatry, 2023)
  • A 2025 study of U.S. communities found that the increased risk for schizophrenia in some populations corresponded more to structural inequities than genetic risk. (American Journal of Psychiatry, 2025)
  • Males and females have approximately the same risk of schizophrenia over a lifetime. However, males are typically diagnosed 3 to 5 years earlier, and the nature of symptoms may differ. (Frontiers in Psychiatry, 2025)

Schizophrenia and violence statistics

  • A review of violent crime in 15 countries found that males with schizophrenia were 4.5 times more likely to commit a violent crime than those without schizophrenia. Females with schizophrenia were 10 times more likely to do so than females without the condition. (JAMA Psychiatry, 2021)
  • Despite this, the prevalence of violent acts committed by people with schizophrenia is still relatively low, with a risk of less than 1 in 4 for males and less than 1 in 20 for females over 35 years. (JAMA Psychiatry, 2021) 
  • Most of the increased risk for violent crimes committed by those with schizophrenia is accounted for by associated substance abuse. (JAMA, 2009)

Co-occurring disorders and schizophrenia

People with schizophrenia can also have co-occurring medical conditions. The following figures represent the percentage of people with schizophrenia who have the specified co-occurring mental health issue:

  • Depressive symptoms: 30%-54%
  • Post-traumatic stress disorder: 29%
  • Obsessive-compulsive disorder: 23%
  • Panic disorder: 15%

The Recovery Village, 2026

Treating schizophrenia

Unfortunately, only around 30% of people with schizophrenia worldwide receive regular treatment; the highest percentage of people not receiving care also had the lowest income, according to the Bulletin of the World Health Organization.

“Almost every individual who is diagnosed with schizophrenia will require medication treatment, usually with an antipsychotic medication,” says Ho. She says that atypical antipsychotics are often utilized, which manage symptoms of schizophrenia such as hallucinations and delusions.

“Many times, patients will have to go through at least a couple of different medication trials to find the right type of medication and dosage for them,” says Ho. She adds that clozapine is currently the most effective treatment when other medications have failed.

Cognitive behavioral therapy (CBT) with a mental health professional is the most effective form of therapy for schizophrenic patients, according to Ho. She explains that CBT teaches a patient how to manage thoughts and behaviors as well as identify triggers for a psychotic episode.

Early intervention can have a significant impact on people with schizophrenia. Schizophrenia symptoms are often worse in the early stages of the illness, which is when the risk of suicide is highest. The majority of people with schizophrenia get better over time, not worse. In fact, 20% of people will get better within five years of developing symptoms. Because schizophrenia may be genetic, people with family members who have schizophrenia or a history of psychotic symptoms may seek mental health services to detect schizophrenia and begin treatment as early as possible. 

Save on schizophrenia medication

The socio-economic impact of schizophrenia

The ripple effects of schizophrenia extend far beyond the individual, creating significant challenges for families, healthcare systems, and national economies. These socioeconomic impacts are a stark reminder of the condition’s broad societal cost.

Economic burden

Schizophrenia is one of the most expensive mental illnesses, largely due to its chronic nature and the need for long-term care:

  • Direct Healthcare Costs: These include hospitalizations, emergency room visits, medication, outpatient therapy, and long-term residential care.
  • Indirect Costs: Far outweighing direct costs, these include: 
    • Lost Productivity: Due to unemployment, underemployment, disability, and premature mortality. Many individuals struggle to maintain consistent employment, leading to significant personal and national economic losses.
    • Caregiver Burden: The often unpaid labor of family members providing care, which can impact their own employment and well-being.
    • Criminal Justice System Involvement: Higher rates of homelessness and minor offenses can lead to increased interaction with law enforcement and incarceration, adding to societal costs.

The economic burden of schizophrenia in the U.S. (combining direct and indirect costs) has been estimated to be around $63 million annually. (The Recovery Village, 2026)

Social stigma and discrimination

Perhaps one of the most insidious costs of schizophrenia is pervasive social stigma and discrimination:

  • Misconceptions: Fueled by sensationalized media portrayals, misconceptions (e.g., “schizophrenics are violent,” “they have split personalities”) lead to fear and avoidance.
  • Impact on Relationships: Stigma can lead to social isolation, making it difficult to form friendships and romantic relationships and to maintain family connections.
  • Discrimination: Individuals with schizophrenia often face discrimination in housing, employment, and even healthcare, limiting their opportunities and exacerbating their illness. Many feel dehumanized and marginalized.
  • Internalized Stigma: Some individuals internalize these negative societal views, leading to low self-esteem, hopelessness, and a reduced likelihood of seeking or adhering to treatment.

This wall of prejudice is a significant barrier to recovery, arguably as debilitating as the symptoms themselves.

Impact on Employment and Education

The early onset of schizophrenia often coincides with critical periods of educational and vocational development, leading to profound impacts:

  • Education: Many individuals experience academic decline or drop out of school, interrupting their educational trajectory and limiting future opportunities.
  • Employment: Rates of unemployment among individuals with schizophrenia are high. Even among those employed, underemployment is common. This isn’t due to a lack of desire or ability for many, but rather a combination of symptom interference, cognitive deficits, medication side effects, and discrimination.
  • Poverty and Homelessness: The difficulties in maintaining employment contribute significantly to high rates of poverty and homelessness within this population. An estimated one-third of homeless individuals have a serious mental illness, with schizophrenia being a major contributor.

These statistics paint a grim picture, but they also highlight clear areas where targeted interventions, like supported employment programs and anti-stigma campaigns, can make a profound difference.

The future of schizophrenia research and treatment

In the last few decades, the development of atypical antipsychotics has improved the treatment of symptoms such as delusions and hallucinations. Compared to older medications, they have fewer adverse effects such as tardive dyskinesia, a movement disorder. However, they still have potential side effects such as weight gain and sedation. And they don’t work as well for negative symptoms or trouble with thought processes. 

But new medications are being researched and developed. They work on a variety of brain receptors and chemicals, and so may be more effective for different symptoms. And many so far show only mild side effects.

There are also ongoing efforts to reduce the stigma around schizophrenia and other mental health conditions. Organizations like NAMI (National Alliance on Mental Illness) lead efforts to create or change policy, educate the public, and support individuals and families.

Browse drugs A-Z: